Article info
PDFA difficult case
Iatrogenic cerebral radiation necrosis
- Correspondence to Lars-Henrik Krarup, Department of Neurology, Rigshospitalet, København, Denmark; lars-henrik.krarup.01{at}regionh.dk
Citation
Iatrogenic cerebral radiation necrosis
Publication history
- Accepted May 15, 2021
- First published May 28, 2021.
Online issue publication
January 10, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Successful treatment of quadriparesis from radiation myelopathy with bevacizumab in a patient with metastatic breast cancer
- Overview of the current concepts in the management of arteriovenous malformations of the brain
- Radiation-induced optic neuropathy: a review
- Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation
- Radiation and the nervous system
- Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome
- Endovascular superselective treatment of brain tumors: a new endovascular era? A quick review
- Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody
- Treatment of tongue telangiectasia in a patient with hereditary haemorrhagic telangiectasia
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD